Articles by Waters Corporation

The chemical and materials science industries are under increasingly public and regulatory scrutiny to improve their sustainability credentials. Join Ben MacCreath from Waters Corporation to discuss how their analytical solutions can help address some of the major concerns, including safety of consumer products.



UniSpray is a novel atmospheric ionization technique that provides increased peak response, enabling ultra-trace detection of PFAS and other contaminants.

October 4, 2021 at 3pm BST | 10am EST | 4pm CEST
Join global industry and regulatory experts as they discuss current hot topics in extractables and leachables (E&L) testing for pharmaceuticals, biopharmaceuticals and medical devices.




Combining the benefits of the ACQUITY APC System with the ACQUITY UPLC Refractive Index (RI) Detector and the ACQUITY QDa Mass Detector yields laboratory efficiencies.

The selection of appropriate column chemistries to separate eighteen polymer additives are routinely monitored in extractables and leachables (E&L) workflows.

A flexible analytical system was used in conjunction with a well-defined informatics workflow to elucidate degradation markers in Li-Ion battery electrolytes.

Combining the APC System with WinGPC UniChrom™ software allows researchers to increase the peak capacity of their research.

Collaborative efforts at Virginia Tech University drive better materials through polymer innovation and additive manufacturing.



⦁ How to use the ACQUITY APC system with aggressive solvent compatible p-QSM technology to support gradient polymer elution chromatography (GPEC).
⦁ Selecting the appropriate detector for enhanced performance and insight.

⦁ How equipping LC with multi-detection technology enables achieving high quality, high-resolution, and rapid sample analysis.
⦁ Leverage LS and RI detectors and viscometer technologies to calculate absolute molecular weight, hydrodynamic radius, and structure of the materials.

⦁ Determine polymer properties such as molecular weight, dispersity, and branching/conformation.
⦁ How to differentiate molecular structure across the molecular weight distribution.

⦁ Reduce run time and solvent consumption by scaling both isocratic and gradient methods using the Alliance HPLC.
⦁ Utilization of the Waters Columns Calculator for scaling isocratic and gradient methods.

⦁ Develop a high performance and robust method for the analysis of formoterol, budesonide, and related compounds.
⦁ Show the straightforward method development capabilities of the ACQUITY™ Arc™ System in combination with Empower™ 3 Chromatographic Data System and S-Matrix Fusion QbD® Software.

⦁ Benefits of utilizing a custom library in the targeted analysis of migration samples.
⦁ Insight into how proposed workflow is used in identifying targeted and untargeted photoinitiators in migration studies.

-A detailed approach to data integrity aids regulatory compliance.
-Advanced technology with automation capabilities can help reduce risks.
-Data solutions include AI, software containers, cloud technology, and more.

Explore the analytical potential of the AQbD approach for achieving high-performance separations of formoterol, budesonide, and its related compounds.

The benefits of using QuanRecovery Vials for trace analysis of fatty acids in RPLC-MS based workflows.

In this application note, infliximab and trastuzumab were separated on a BioResolve SCX mAb Column, and their charge variant fractions were collected using a Waters Fraction Manager-Analytical (WFM-A).

The development and validation of a robust, quantitative method for the routine determination of a wide range of LC-amenable pesticides following QuEChERS (DisQuE dispersive sample preparation) procedure and LC-MS/MS

This document is designed to help the user performing intact and/or subunit protein analysis evaluate the performance or suitability of the instrument by undertaking a simple system check (SC) and running of QC standards.

The benefits of using QuanRecovery Vials for trace analysis of fatty acids in RPLC-MS based workflows.

Explore the analytical potential of the AQbD approach for achieving high-performance separations of formoterol, budesonide, and its related compounds.

In this application note, infliximab and trastuzumab were separated on a BioResolve SCX mAb Column, and their charge variant fractions were collected using a Waters Fraction Manager-Analytical (WFM-A).